These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8738112)

  • 21. [The effect of gemfibrozil on serum apo C II and C III in diabetic hyperlipidemia].
    Tong N; Liang J
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):409-11. PubMed ID: 1814823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene.
    Raposo HF; Patrício PR; Simões MC; Oliveira HC
    J Nutr Biochem; 2014 Jun; 25(6):669-74. PubMed ID: 24746832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men.
    Dumont M; Mauriège P; Bergeron J; Després JP; Prud'homme D
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1136-43. PubMed ID: 11477498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators.
    Vinik AI; Colwell JA
    Diabetes Care; 1993 Jan; 16(1):37-44. PubMed ID: 8422814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM.
    Garg A; Grundy SM
    Diabetes; 1989 Mar; 38(3):364-72. PubMed ID: 2917701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
    Jen SL; Chen JW; Lee WL; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)].
    Palel G; Coman A; Petrovanu R; Ungureanu D; Cojocaru M
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):120-2. PubMed ID: 10756782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.
    Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
    Diabetes Care; 1997 Jun; 20(6):913-21. PubMed ID: 9167099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the influence of fish oil and gemfibrozil on levels of serum lipoprotein in endogenous hypertriglyceridemia].
    Szostak-Wegierek D; Nowicka G
    Pol Arch Med Wewn; 1994 Aug; 92(2):184-91. PubMed ID: 7800588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.
    Avogaro A; Beltramello P; Marin R; Zambon S; Bonanome A; Biffanti S; Confortin L; Manzato E; Crepaldi G; Tiengo A
    Atherosclerosis; 1995 Feb; 113(1):117-24. PubMed ID: 7755647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.
    McManus RM; Jumpson J; Finegood DT; Clandinin MT; Ryan EA
    Diabetes Care; 1996 May; 19(5):463-7. PubMed ID: 8732710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
    Schweitzer M; Tessier D; Vlahos WD; Leiter L; Collet JP; McQueen MJ; Harvey L; Alaupovic P
    Atherosclerosis; 2002 May; 162(1):201-10. PubMed ID: 11947915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study.
    Leaf DA; Connor WE; Illingworth DR; Bacon SP; Sexton G
    JAMA; 1989 Dec; 262(22):3154-60. PubMed ID: 2681858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum magnesium status during lipid-lowering drug treatment in non-insulin-dependent diabetic patients.
    Haenni A; Ohrvall M; Lithell H
    Metabolism; 2001 Oct; 50(10):1147-51. PubMed ID: 11586485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.
    Axelrod L; Camuso J; Williams E; Kleinman K; Briones E; Schoenfeld D
    Diabetes Care; 1994 Jan; 17(1):37-44. PubMed ID: 8112187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gemfibrozil in the elderly. Effects on lipid metabolism].
    Brosche T; Kipfmüller G
    Fortschr Med; 1996 May; 114(13):157-60. PubMed ID: 8964557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ; Song YM; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fish oil in people with type 2 diabetes mellitus.
    Farmer A; Montori V; Dinneen S; Clar C
    Cochrane Database Syst Rev; 2001; (3):CD003205. PubMed ID: 11687050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-lowering efficacy of psyllium hydrophilic mucilloid in non insulin dependent diabetes mellitus with hyperlipidaemia.
    Gupta RR; Agrawal CG; Singh GP; Ghatak A
    Indian J Med Res; 1994 Nov; 100():237-41. PubMed ID: 7829159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.